EUVIMEDEUVIMED entdecken
EditorialKommentar

Targeting neutrophilic inflammation in COPD: rethinking, refining and reprogramming

Lydia J Finney iD, Katharine M Lodge iD

European Respiratory Journal · 2026-11 · 68 (5) · 2601496

DOI: 10.1183/13993003.01496-2026 ↗

Kurz gefasst

Editorial in der Zeitschrift European Respiratory Journal, online erschienen am 05.11.2026. Verfasst von Lydia J Finney und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Heart and Lung Institute, Imperial College London, London, UK l.finney@imperial.ac.uk. Die Arbeit nennt 24 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Extract Despite recent advances in type 2 (T2)-targeted biologics, which have been shown to reduce exacerbations and improve lung function in COPD patients with evidence of T2 inflammation, the majority of COPD patients exhibit a neutrophil predominant pattern of airway inflammation. Neutrophilic inflammation is associated with more frequent exacerbations [1], more rapid lung function decline [2] and alveolar destruction. Consequently, there remains a large unmet need for effective treatments targeting non-T2 inflammation in COPD. Myeloperoxidase (MPO), an abundant neutrophil granule protein, plays an essential role in the destruction of pathogens following engulfment by neutrophils, synergising with additional killing mechanisms, including proteolytic enzymes contained within neutrophil granules. However, release of MPO during neutrophil degranulation, neutrophil extracellular trap (NET)-osis or cell death leads to lung tissue damage. Consequently, MPO has emerged as a promising candidate target for this neutrophilic phenotype, supported by encouraging pre-clinical data [3].

Autor:innen und Institutionen

  • National Heart and Lung Institute, Imperial College London, London, UK l.finney@imperial.ac.uk.
  • National Heart and Lung Institute, Imperial College London, London, UK.

ORCID-Profile: Lydia J Finney, Katharine M Lodge

Zitieren

APA

Finney, L. J., & Lodge, K. M. (2026). Targeting neutrophilic inflammation in COPD: rethinking, refining and reprogramming. European Respiratory Journal, 68(5), 2601496. https://doi.org/10.1183/13993003.01496-2026

Vancouver

Finney LJ, Lodge KM. Targeting neutrophilic inflammation in COPD: rethinking, refining and reprogramming. European Respiratory Journal. 2026;68(5):2601496. doi:10.1183/13993003.01496-2026

BibTeX
@article{Finney2026,
  author = {Finney, Lydia J and Lodge, Katharine M},
  title = {Targeting neutrophilic inflammation in COPD: rethinking, refining and reprogramming},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {5},
  pages = {2601496},
  doi = {10.1183/13993003.01496-2026}
}
Kostenlos starten →